27-01-2021 21:00 via medpagetoday.org

Bimagrumab Benefits Patients With Obesity, Type 2 Diabetes

(MedPage Today) -- Study Authors: Steven B. Heymsfield, Laura A. Coleman, et al.Target Audience and Goal Statement: Endocrinologists, primary care physiciansThe goal of this study was to evaluate the efficacy and safety of the monoclonal antibody...
Read more »